Loading review totals...
in person
Here is the sample AD
Map
Medical Director & Staff
Public profile data for Reneux Med and Day Spa Hawaii references Dr. Irene Ohbe-Arakaki and Dr. Irene Ohbe-Arakaki, M.D.** is the Owner and Medical Director. She is a Honolulu native, graduated from the University of Puget Sound and the University of Hawaii John A. Burns School of Medicine, and completed her post-graduate training at UC Davis Medical Center and the University of Hawaii's Residency Program. Dr. Arakaki has advanced education in Aesthetic and Laser Medicine and is a member of the American Society for Laser Medicine and Surgery. She is bilingual in English and Japanese in medical director or clinical leadership roles. ABOM certification is not currently confirmed in the directory dataset, so patients may want to verify obesity-medicine credentials directly. Additional medical staff mentioned in public sources include Dr. Irene Ohbe-Arakaki, Dr. Arakaki, and Dr. Anne Tanabe, which suggests multidisciplinary clinical coverage.
Medical Director(s):
- Dr. Irene Ohbe-Arakaki
- Dr. Irene Ohbe-Arakaki, M.D.** is the Owner and Medical Director. She is a Honolulu native, graduated from the University of Puget Sound and the University of Hawaii John A. Burns School of Medicine, and completed her post-graduate training at UC Davis Medical Center and the University of Hawaii's Residency Program. Dr. Arakaki has advanced education in Aesthetic and Laser Medicine and is a member of the American Society for Laser Medicine and Surgery. She is bilingual in English and Japanese
Medical Staff:
- Dr. Irene Ohbe-Arakaki
- Dr. Arakaki
- Dr. Anne Tanabe
- Dr. Tanabe
GLP-1 Medications Offered
Common GLP-1 medications by generic and brand name, including compounded options.
| Medication | Generic | Form | Primary Use | Clinic Availability |
|---|---|---|---|---|
| Ozempic | Semaglutide | Weekly injection | Type 2 Diabetes | Possible |
| Wegovy | Semaglutide | Weekly injection | Weight loss | Possible |
| Rybelsus | Semaglutide | Daily oral tablet | Type 2 Diabetes | Possible |
| Mounjaro | Tirzepatide (Dual GIP/GLP-1 agonist) | Weekly injection | Type 2 Diabetes | Possible |
| Zepbound | Tirzepatide (Dual GIP/GLP-1 agonist) | Weekly injection | Weight loss | Possible |
| Compounded Semaglutide | Semaglutide | Compounded formulation | Weight management / metabolic care | Not confirmed |
| Compounded Tirzepatide | Tirzepatide | Compounded formulation | Weight management / metabolic care | Not confirmed |
Care & Access Snapshot
Quick operational snapshot to bridge medication availability and cost details.
Care Model
Consultation: in person
Insurance Concierge: No
Reported medications: 0 | Possible: 5
Medication Access Signals
Reported: No medications explicitly reported yet.
Possible: Ozempic, Wegovy, Rybelsus, Mounjaro
Priced Products Found: Semaglutide brand (Ozempic/Wegovy)
Pricing Snapshot
Pricing rows are mapped to likely medication names from clinic/source text. Benchmark columns show actual dollar averages for this product in city, state, and national datasets.
| Medication | Monthly Membership | Out-of-Pocket Estimate | Total Cost | City Avg Total Cost | State Avg Total Cost | National Avg Total Cost |
|---|---|---|---|---|---|---|
| Semaglutide brand (Ozempic/Wegovy) | Not listed | $35 | $35 | $268 | $268 | $311 |
Dose Titration Pricing (Estimated)
Higher doses can increase monthly spend. This model applies standard GLP-1 titration pathways and should be verified with the clinic.
Semaglutide brand (Ozempic/Wegovy)
Estimated from this clinic's listed monthly total cost baseline ($35).
| Titration Window | Dose | Price Delta | Estimated Monthly Total |
|---|---|---|---|
| Weeks 1-4 | 0.25 mg weekly | Base | $35 |
| Weeks 5-8 | 0.5 mg weekly | +8% | $38 |
| Weeks 9-12 | 1.0 mg weekly | +18% | $41 |
| Weeks 13-16 | 1.7 mg weekly | +30% | $46 |
| Week 17+ | 2.4 mg weekly | +42% | $50 |
Clinic Pricing Submission
Clinic representatives can add current pricing by medication and dose. Entries are saved in-browser for quick updates and review.
Total Cost of Care (TCOC)
Monthly Average
$35
Annual Expected Cost
$420
GLP-1 treatment is often long-term. Annual cost assumes 12 months at the clinic's monthly average total cost.
Simple GLP-1 Weight Loss Calculator
Estimated Weight Loss: -
Estimated Weight at Outcome: -
Estimated Time to Outcome: -
Estimated Total Cost to Outcome: -
12-Month Projection: -
Evidence Basis: -
Estimated by GLP-1 Type
Semaglutide
-
Monthly Cost: -
Estimated Weight Loss: -
Estimated Outcome Weight: -
Estimated Time: -
Estimated Total Cost: -
Evidence: -
Tirzepatide
-
Monthly Cost: -
Estimated Weight Loss: -
Estimated Outcome Weight: -
Estimated Time: -
Estimated Total Cost: -
Evidence: -
Estimates use study-average percent weight loss by medication type and your clinic's listed monthly cost for that medication row.
Compounded entries are modeled using published outcomes of the corresponding molecule and are not FDA-reviewed compounded-product efficacy claims.
Featured Ad
This ad appears between Reviews and Nearby Clinics.
Nearby Clinics
Claim Your Profile
Following the instructions to Claim this profile to edit the listings or upgrade.
3 options: Claimed (Free), Advanced, Elite.
Request an Appointment
Paid memberships can accept appointment requests directly from the profile.
Loading appointment tools...
Reneux Med and Day Spa Hawaii Reviews
Review Reneux Med and Day Spa Hawaii and Report your GLP-1 Price.
Email is required for verification and is never shown publicly.
Analyzing review themes...
Loading reviews...